AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (649.2 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Therapeutic drug monitoring for promotion of rational medication in the elderly: Overview, challenges and opportunities

Bolin Zhua,b,c,dYuanchao Zhua,b,c,dDi Chena,b,c,d( )Pengfei Jina,b,c,d( )
Department of Pharmacy, Beijing Hospital, Beijing 100730, China
National Center of Gerontology, Beijing 100730, China
Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China
Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital), Beijing 100730, China
Show Author Information

Abstract

In the context of rapid development of clinical pharmacy in China, therapeutic drug monitoring (TDM) has become a vital tool for rational medication and is widely concerned. TDM combines the knowledge of pharmacokinetic and pharmacodynamic to optimize individualized drug therapy, which can ensure drug efficacy, avoid excessive accumulation of drug, and reduce drug-drug interaction. Drug therapy in elderly patients is often accompanied by age-related changes in the processes of drug absorption, distribution, metabolism and elimination. The pharmacokinetic and pharmacodynamic behaviors of elderly patients differ significantly from those of normal adult population, which may lead to treatment failure or drug toxicity. TDM allows clinician to optimize dose and provides the most viable approach to individualize therapy. By researching the published literature, it is found that little data are available with respect to the special effect of TDM in elderly patients. Herein, focusing on elderly patients, we summarize types of commonly monitored drugs, therapeutic windows, and track the tends and opportunities of TDM. The purpose of this paper is to call for more attention to TDM in elderly patients. TDM should be implemented for the elderly to overcome age-related differences between dose and plasma concentration, to monitor possible drug-drug interaction, and to guide dose adjustment.

References

【1】
【1】
 
 
Precision Medication

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhu B, Zhu Y, Chen D, et al. Therapeutic drug monitoring for promotion of rational medication in the elderly: Overview, challenges and opportunities. Precision Medication, 2024, 1(1). https://doi.org/10.1016/j.prmedi.2024.10.006

494

Views

30

Downloads

5

Crossref

Received: 14 June 2024
Revised: 25 July 2024
Accepted: 07 August 2024
Published: 30 October 2024
© 2024 Chinese General Practice Publishing House Co., Ltd.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).